Search results for "slas europe 2018"

EKF Quo-Test HbA1c analyzer successfully evaluated at Swansea University Diabetes Research Unit

In this poster presentation from AOAC, discover how IC-MS can offer an effective solution to longstanding problematic contaminant analysis

CHANGE-MS study confirms safety of GNbAC1 and reveals positive results related to neuroprotection in Multiple Sclerosis

Learn how one U.S. analytical lab has struck a partnership with its technology provider to become an industry leader in drinking water analysis

Clinical study results suggest individuals with type I or II diabetes may achieve improved glycaemic control with Tresiba

In a guest editorial from H.E.L Group, explore how pressurized bioreactors and synthetic biology can mitigate the dangerous effects of climate change

Rapid human ID STR assays for forensic casework, databasing and relationship testing.

Global leaders convene to map new paths to diagnose and treat Alzheimer’s, Multiple Sclerosis, and other neurodegenerative diseases that afflict one in six people

New transfection reagent is an efficient, stable, and safe delivery system leading to 100% mRNA encapsulation for comparable LNP delivery

The Ion Torrent Genexus Dx Integrated Sequencer enables rapid NGS for diagnostic applications and clinical research

Expanding CRISPR screening technology to ex vivo primary T cells through a combined lentiviral and electroporation approach

Acquisition expands portfolio of Lab Products & Services division, incorporating unique technology for cell analysis in biopharma applications

Certified quality of analytical services for developers of biologics and biosimilars

Scientists at the National Center for Research on Human Genomics are at the forefront of groundbreaking research to develop new drugs for major diseases

The new state-of-the-art complex further strengthens its commitment to the greater Loveland, Colorado community

Research confirms the unmet need for an effective alternative to unenhanced MRI and a safe alternative to GBCAs

Discover the latest technology for the identification of structural variants (SVs) within the human genome